POST FORUM SITE
ATTENDEES
SPEAKERS
PRESENTERS
​​​EXHIBITORS
INVESTORS
SPONSORS
SUPPORTERS
​​​SEEDS


​ABOUT 19th BEF

ATTENDING INVESTORS & ANALYSTS IN 2018 INCLUDE:

AbbVie Ventures
Abingworth LLP
Accequa AB
ACXIT Capital Management GmbH
Advent France Biotechnology
Aglaia Oncology Funds
ALSA Holdings Ltd.
aMoon Fund
AmorChem Venture Fund
Andera Partners
Aravis SA
Arthurian Life Sciences
Asklepios Advisors
Aston LS Capital
AstraZeneca BioVentureHub
Atelix Ltd.
ATGN Consulting
Auriga Partners
Back Bay HealthCare Capital
BaselArea.swiss
BaseLaunch
Bay City Capital LLC
BB Pureos Bioventures
Bellevue
Bergmann zur Hausen & Cie. GmbH
Bio Medi Gene Ventures
BioGeneration Ventures
BioMedInvest
BioMedPartners AG
BioPharma Advisory
BioSeed Capital
BioSense Global LLC
BIOSTART
Biotech Alliances International, Inc.
Biotrial Research SAS
Bird & Bird LLP
BLAC-BioPharma UG
Bohe Angel Fund
Bootstrap Europe
Bpifrance
Breslin AG
Brothers & Partners Europe
Bryan, Garnier & Co
C-Bridge Capital
Capital Grand Est
Capricorn Venture Partners
CDR-Life AG
Cederberg GmbH
Colpman Consulting Ltd.
Corinthian Financial Management Ltd
Creathor Ventures
Cukierman & Co. Life Sciences
DDF Ventures B.V.
Droia NV
E. Gutzwiller & Cie, Banquiers
Earlybird Health-Tech Management GmbH & Co. KG
Economic and Trade Department, Embassy of Israel
Edison Group
EIT Health e.V.
Ekins Guinness LLP
Epidarex
Ernst & Young AG
Esperante Ventures
Euronext
European Investment Bank
EVA - the Basel life sciences start-up agency
Fondation Eclosion
Fosun Group
Fraser Finance
FreeMind Group
Gilde Healthcare
Gimv
GL Capital Group
goetzpartners Corporate Finance GmbH
Grabulovski Consulting Services
Guggenheim Securities
H.C. Wainwright & Co.
H.C. Wainwright & Co., LLC
Hadean Ventures
HBM Partners AG
Health Passion Fund
HealthCap
HealthCare Royalty Partners
High-Tech Gruenderfonds Management GmbH
Hoffmann & Co AG
ICF Consult (Switz.)
Illumina Ventures
IMI Consulting GmbH

Indelve
Independent
INKEF Capital BV
Innogest
Instinctif Partners
Inveready Asset Management
investiere Verve Capital Partners
Investor Verlag
IP Group Plc
IPF Partners
Jina Ventures, Inc.
JPIF
Kronos Advisors
LSFA
LSP
LSWorks LLC
Lundbeckfond Emerge
M Ventures
MaxPro Ventures
Medical Valley Ventures
Medicxi Ventures
MedVenture GmbH
Momentum Biotech
Monitus Research
MP Healthcare Venture Management
MRL Ventures Fund
New Science Fund
Nextech Invest Ltd.
Norgine Ventures
Novartis Venture Fund
Novo Holdings A/S
Novo Ventures
Oberland Capital
Omega Funds
OrbiMed
Paulson Investment Company
PharmaVentures Ltd.
Pharmstandard Ventures
Philimmune, LLC
PM Equity Partner
PMV
Positive Capital
Prescient Healthcare Group
Primer Capital
Privateq Advisors AG
Quan Capital
RBC Capital Markets
RBV Capital
Redalpine Venture Partners
Roche Partnering
Roche Venture Fund
Salus Partners SA
Schroder Adveq
Seroba Life Sciences
Seventure Partners
Silicon Valley Bank
Sofimac Innovation
Staatz BD & Strategy
Staatz Business Development & Strategy
Stifel
Strategic Swiss Partners
Suenos Advisors Est.
Sunstone Capital A/S
Takeda Ventures, Inc.
The Coulter Partnership Ltd.
The Fulford Group Ltd.
The German Accelerator Life Sciences (GALS)
Torreya Partners, LLP
Trendlines Medical
Turos Capital AG
TVM Capital China Limited
TVM Capital Life Science
UCB Ventures
V-Bio Ventures
Valor Management SA
valuationLAB AG
Ventac Partners
Venture Valuation AG
Versant Venture
VI Partners AG
Vida Ventures
Virdis Group
Vogel BioC
Wellington Partners
Xeraya Capital
YA Global, LP
Ysios Capital Partners

* More to be announced. Last updated on 19.09.2018